Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Rosemary T. Smith"'
Autor:
M. Kathryn Dahlgren, Rosemary T. Smith, Deniz Kosereisoglu, Kelly A. Sagar, Ashley M. Lambros, Celine El-Abboud, Staci A. Gruber
Publikováno v:
npj Women's Health, Vol 2, Iss 1, Pp 1-12 (2024)
Abstract The endocannabinoid system is involved in gynecological functions, with cannabidiol (CBD) demonstrating promise for alleviating menstrual-related symptoms. This survey-based, quasi-experimental study assessed pro re nata (PRN) use of a comme
Externí odkaz:
https://doaj.org/article/2cf609a8f01c4d54a8d9c1460fd737c1
Autor:
Ashley M. Lambros, Kelly A. Sagar, M. Kathryn Dahlgren, Deniz Kosereisoglu, Celine El-Abboud, Rosemary T. Smith, Staci A. Gruber
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Increasing numbers of individuals have access to cannabinoid-based products containing various amounts of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Exposure to specific cannabinoids likely influences outc
Externí odkaz:
https://doaj.org/article/00354a0515c24d38bc5734d0cdf3b596
Autor:
Mary Kathryn Dahlgren, Ashley M. Lambros, Rosemary T. Smith, Kelly A. Sagar, Celine El-Abboud, Staci A. Gruber
Publikováno v:
Communications Medicine, Vol 2, Iss 1, Pp 1-10 (2022)
Dahlgren et al. conduct an open-label phase 2 trial of a full-spectrum, high-cannabidiol product in 14 patients with moderate-to-severe anxiety. Anxiety is significantly reduced and the drug well-tolerated with no serious adverse events.
Externí odkaz:
https://doaj.org/article/1ed66b8fe7e3469789f38035613352a3
Autor:
Rosemary T. Smith, Staci A. Gruber
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2023)
The majority of states have fully legalized the use of medical cannabis (MC), and nearly all other states allow limited access to cannabidiol (CBD), a non-intoxicating constituent of cannabis often touted for a range of therapeutic indications. Furth
Externí odkaz:
https://doaj.org/article/d9d9bb2aba3d498ba920589979b8513c
Autor:
Staci A. Gruber, Kelly A. Sagar, Mary K. Dahlgren, Atilla Gonenc, Rosemary T. Smith, Ashley M. Lambros, Korine B. Cabrera, Scott E. Lukas
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2018)
The vast majority of states have enacted full or partial medical marijuana (MMJ) programs, causing the number of patients seeking certification for MMJ use to increase dramatically in recent years. Despite increased use of MMJ across the nation, no s
Externí odkaz:
https://doaj.org/article/abac368504264c6591ea134fbd44965b
Publikováno v:
Cannabis. 4:47-59
Background: To date, no studies have directly assessed potential cannabis use disorder (CUD) in medical cannabis (MC) patients pre- vs post-MC treatment. Given that MC patients use cannabis for symptom alleviation rather than intoxication, we hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1151a487e039f8de8d4c942c2be9ef26
https://doi.org/10.26828/cannabis/2021.02.004
https://doi.org/10.26828/cannabis/2021.02.004
Autor:
Mary Kathryn Dahlgren, Atilla Gonenc, Kelly A. Sagar, Rosemary T. Smith, Ashley M. Lambros, Celine El-Abboud, Staci A. Gruber
Publikováno v:
Cannabis and cannabinoid research. 7(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708c7ab5c21b6e8bc601db10b844d732
https://pubmed.ncbi.nlm.nih.gov/36367574
https://pubmed.ncbi.nlm.nih.gov/36367574
Autor:
M. Kathryn Dahlgren, Celine El-Abboud, Ashley M. Lambros, Kelly A. Sagar, Rosemary T. Smith, Staci A. Gruber
Publikováno v:
Menopause (New York, N.Y.). 29(9)
Expanding access to legal cannabis has dovetailed with increased interest in medical cannabis (MC) use; however, there is a paucity of research examining MC use to alleviate menopause-related symptoms. This survey study assessed patterns of MC use in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2128019d8a347a8205cd143e5c4568f5
https://pubmed.ncbi.nlm.nih.gov/35917529
https://pubmed.ncbi.nlm.nih.gov/35917529
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
Autor:
Staci A Gruber, Kelly A Sagar, Mary Kathryn Dahlgren, Megan T Racine, Rosemary T Smith, Scott E Lukas
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Currently, 25 states and Washington DC have enacted full medical marijuana (MMJ) programs while 18 states allow limited access to MMJ products. Limited access states permit low (or zero) tetrahydrocannabinol (THC) and high cannabidiol (CBD) products
Externí odkaz:
https://doaj.org/article/33a013e558aa4b80a87b7e27f0f1e7de
Autor:
Mary Kathryn Dahlgren, Ashley M. Lambros, Rosemary T. Smith, Kelly A. Sagar, Celine El-Abboud, Staci A. Gruber
Publikováno v:
Communications medicine. 2(1)
Evidence suggests cannabidiol (CBD) has anxiolytic properties, indicating potential for novel treatment strategies. However, few clinical trials of CBD-based products have been conducted, and none thus far have examined the impact of these products o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65378d2ac2bb628cd5cb6041da06244
https://pubmed.ncbi.nlm.nih.gov/36352103
https://pubmed.ncbi.nlm.nih.gov/36352103